A detailed history of Black Rock Inc. transactions in 23and Me Holding Co. stock. As of the latest transaction made, Black Rock Inc. holds 21,559,196 shares of ME stock, worth $11.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,559,196
Previous 22,467,761 4.04%
Holding current value
$11.9 Million
Previous $20.4 Million 44.11%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$0.4 - $0.91 $363,426 - $826,794
-908,565 Reduced 4.04%
21,559,196 $11.4 Million
Q4 2023

Feb 13, 2024

BUY
$0.71 - $0.97 $2.04 Million - $2.79 Million
2,872,405 Added 14.66%
22,467,761 $20.4 Million
Q3 2023

Nov 13, 2023

BUY
$0.96 - $2.01 $254,637 - $533,146
265,247 Added 1.37%
19,595,356 $19.2 Million
Q2 2023

Aug 11, 2023

BUY
$1.59 - $2.29 $1.45 Million - $2.08 Million
910,127 Added 4.94%
19,330,109 $33.8 Million
Q1 2023

May 12, 2023

BUY
$2.05 - $2.87 $323,135 - $452,389
157,627 Added 0.86%
18,419,982 $42 Million
Q4 2022

Feb 13, 2023

BUY
$2.06 - $3.47 $4.45 Million - $7.5 Million
2,160,319 Added 13.42%
18,262,355 $39.4 Million
Q3 2022

Nov 14, 2022

BUY
$2.6 - $5.12 $12.2 Million - $24 Million
4,683,691 Added 41.02%
16,102,036 $46.1 Million
Q2 2022

Aug 12, 2022

BUY
$2.19 - $3.98 $18.2 Million - $33 Million
8,289,973 Added 264.99%
11,418,345 $28.3 Million
Q1 2022

May 12, 2022

BUY
$3.28 - $7.12 $5.63 Million - $12.2 Million
1,717,071 Added 121.67%
3,128,372 $12 Million
Q4 2021

Feb 10, 2022

BUY
$6.55 - $13.25 $1.67 Million - $3.37 Million
254,230 Added 21.97%
1,411,301 $9.4 Million
Q3 2021

Nov 09, 2021

BUY
$7.29 - $11.0 $8.44 Million - $12.7 Million
1,157,071 New
1,157,071 $10.5 Million

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $143M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.